Effects of N-acetylcysteine on skeletal muscle structure and function in a mouse model of peripheral arterial insufficiency

Journal of Vascular Surgery

Volumn 61, Issue 3, 2015, Pages 777-786

  Roseguini, Bruno T ^a   Silva, Leonardo M ^a   Polotow, Tatiana G ^b   Barros, Marcelo P ^b   Souccar, Caden ^a   Han, Sang W ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDADE CRUZEIRO DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; MALONALDEHYDE; SODIUM CHLORIDE; ANTIOXIDANT; BIOLOGICAL MARKER; COLLAGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; CONFERENCE PAPER; CONNECTIVE TISSUE; CONTROLLED STUDY; DRUG EFFECT; DUCHENNE MUSCULAR DYSTROPHY; EXTENSOR DIGITORUM LONGUS MUSCLE; FATIGUE; FEMORAL ARTERY; GASTROCNEMIUS MUSCLE; HISTOPATHOLOGY; IN VITRO STUDY; LIPID PEROXIDATION; MALE; MOUSE; MUSCLE FUNCTION; MUSCLE ISCHEMIA; NONHUMAN; PERIPHERAL ISCHEMIA; PRIORITY JOURNAL; SKELETAL MUSCLE; SKELETAL MUSCLE STRUCTURE; SOLEUS MUSCLE; TREATMENT DURATION; ANIMAL; BAGG ALBINO MOUSE; CONVALESCENCE; DRUG EFFECTS; EXERCISE TOLERANCE; LIGATION; METABOLISM; MUSCLE CONTRACTION; MUSCLE FATIGUE; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL ARTERIAL DISEASE; PROTEIN CARBONYLATION; SURGERY; TIME; VASCULARIZATION;

ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; COLLAGEN; EXERCISE TOLERANCE; FEMORAL ARTERY; LIGATION; LIPID PEROXIDATION; MALE; MICE, INBRED BALB C; MUSCLE CONTRACTION; MUSCLE FATIGUE; MUSCLE, SKELETAL; OXIDATIVE STRESS; PERIPHERAL ARTERIAL DISEASE; PROTEIN CARBONYLATION; RECOVERY OF FUNCTION; TIME FACTORS;

EID: 84923616226     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2013.10.098     Document Type: Conference Paper

References (53)

1. M.A. Allison, E. Ho, J.O. Denenberg, R.D. Langer, A.B. Newman, and R.R. Fabsitz Ethnic-specific prevalence of peripheral arterial disease in the United States Am J Prev Med 32 2007 328 333
2. M.M. McDermott The magnitude of the problem of peripheral arterial disease: epidemiology and clinical significance Cleve Clin J Med 73 Suppl 4 2006 S2 S7
3. M.M. McDermott, K. Liu, P. Greenland, J.M. Guralnik, M.H. Criqui, and C. Chan Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms JAMA 292 2004 453 461
4. J.G. Regensteiner, W.R. Hiatt, J.R. Coll, M.H. Criqui, D. Treat-Jacobson, and M.M. McDermott The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program Vasc Med 13 2008 15 24
5. D.J. Sieminski, and A.W. Gardner The relationship between free-living daily physical activity and the severity of peripheral arterial occlusive disease Vasc Med 2 1997 286 291
6. J.D. Anderson, F.H. Epstein, C.H. Meyer, K.D. Hagspiel, H. Wang, and S.S. Berr Multifactorial determinants of functional capacity in peripheral arterial disease: uncoupling of calf muscle perfusion and metabolism J Am Coll Cardiol 54 2009 628 635
7. M.M. McDermott, F. Hoff, L. Ferrucci, W.H. Pearce, J.M. Guralnik, and L. Tian Lower extremity ischemia, calf skeletal muscle characteristics, and functional impairment in peripheral arterial disease J Am Geriatr Soc 55 2007 400 406
8. J.G. Regensteiner, E.E. Wolfel, E.P. Brass, M.R. Carry, S.P. Ringel, and M.E. Hargarten Chronic changes in skeletal muscle histology and function in peripheral arterial disease Circulation 87 1993 413 421
9. B. Hedberg, K.A. Angquist, and M. Sjostrom Peripheral arterial insufficiency and the fine structure of the gastrocnemius muscle Int Angiol 7 1988 50 59
10. I.I. Pipinos, S.A. Swanson, Z. Zhu, A.A. Nella, D.J. Weiss, and T.L. Gutti Chronically ischemic mouse skeletal muscle exhibits myopathy in association with mitochondrial dysfunction and oxidative damage Am J Physiol Regul Integr Comp Physiol 295 2008 R290 R296
11. I.I. Pipinos, A.R. Judge, Z. Zhu, J.T. Selsby, S.A. Swanson, and J.M. Johanning Mitochondrial defects and oxidative damage in patients with peripheral arterial disease Free Radic Biol Med 41 2006 262 269
12. M.M. McDermott, L. Ferrucci, J. Guralnik, L. Tian, K. Liu, and F. Hoff Pathophysiological changes in calf muscle predict mobility loss at 2-year follow-up in men and women with peripheral arterial disease Circulation 120 2009 1048 1055
13. M.M. McDermott, K. Liu, L. Tian, J.M. Guralnik, M.H. Criqui, and Y. Liao Calf muscle characteristics, strength measures, and mortality in peripheral arterial disease: a longitudinal study J Am Coll Cardiol 59 2012 1159 1167
14. W.R. Hiatt, J.G. Regensteiner, E.E. Wolfel, M.R. Carry, and E.P. Brass Effect of exercise training on skeletal muscle histology and metabolism in peripheral arterial disease J Appl Physiol 81 1996 780 788
15. J.S. Berger, and W.R. Hiatt Medical therapy in peripheral artery disease Circulation 126 2012 491 500
16. A.R. Judge, and S.L. Dodd Oxidative damage to skeletal muscle following an acute bout of contractile claudication Atherosclerosis 171 2003 219 224
17. A.R. Judge, and S.L. Dodd Xanthine oxidase and activated neutrophils cause oxidative damage to skeletal muscle after contractile claudication Am J Physiol Heart Circ Physiol 286 2004 H252 H256
18. I.I. Pipinos, A.R. Judge, J.T. Selsby, Z. Zhu, S.A. Swanson, and A.A. Nella The myopathy of peripheral arterial occlusive disease: part 2. Oxidative stress, neuropathy, and shift in muscle fiber type Vasc Endovascular Surg 42 2008 101 112
19. M. Zafarullah, W.Q. Li, J. Sylvester, and M. Ahmad Molecular mechanisms of N-acetylcysteine actions Cell Mol Life Sci 60 2003 6 20
20. W.Q. Han, D.L. Zhu, L.Y. Wu, Q.Z. Chen, S.J. Guo, and P.J. Gao N-acetylcysteine-induced vasodilation involves voltage-gated potassium channels in rat aorta Life Sci 84 2009 732 737
21. L.F. Ferreira, and M.B. Reid Muscle-derived ROS and thiol regulation in muscle fatigue J Appl Physiol 104 2008 853 860
22. A. Hernandez, A. Cheng, and H. Westerblad Antioxidants and skeletal muscle performance: "common knowledge" vs. experimental evidence Front Physiol 3 2012 46
23. N.P. Whitehead, C. Pham, O.L. Gervasio, and D.G. Allen N-Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice J Physiol 586 2008 2003 2014
24. I.A. Williams, and D.G. Allen The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice Am J Physiol Heart Circ Physiol 293 2007 H1969 H1977
25. D. Chalothorn, and J.E. Faber Strain-dependent variation in collateral circulatory function in mouse hindlimb Physiol Genomics 42 2010 469 479
26. A. Helisch, S. Wagner, N. Khan, M. Drinane, S. Wolfram, and M. Heil Impact of mouse strain differences in innate hindlimb collateral vasculature Arterioscler Thromb Vasc Biol 26 2006 520 526
27. J.M. McClung, T.J. McCord, S. Keum, S. Johnson, B.H. Annex, and D.A. Marchuk Skeletal muscle-specific genetic determinants contribute to the differential strain-dependent effects of hindlimb ischemia in mice Am J Pathol 180 2012 2156 2169
28. de Senzi Moraes, R. Pinto, R. Ferretti, L.H. Moraes, H.S. Neto, and M.J. Marques N-Acetylcysteine treatment reduces TNF-alpha levels and myonecrosis in diaphragm muscle of mdx mice Clin Nutr 32 2013 472 475
29. C. Souccar, C. Goncalo Mdo, S. Buck Hde, M.T. Lima-Landman, and A.J. Lapa Mild dystrophic damage in the androgen-sensitive levator ani muscle of the mdx mouse Neuromuscul Disord 15 2005 48 56
30. R.I. Close Dynamic properties of mammalian skeletal muscles Physiol Rev 52 1972 129 197
31. T. Kinnaird, E. Stabile, M.S. Burnett, M. Shou, C.W. Lee, and S. Barr Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms Circulation 109 2004 1543 1549
32. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 1976 248 254
33. I.E. Hoefer, N. van Royen, and M.M. Jost Experimental models of arteriogenesis: differences and implications Lab Anim (NY) 35 2006 36 44
34. M.A. Ziegler, M.R. Distasi, R.G. Bills, S.J. Miller, M. Alloosh, and M.P. Murphy Marvels, mysteries, and misconceptions of vascular compensation to peripheral artery occlusion Microcirculation 17 2010 3 20
35. M.M. McDermott, P. Greenland, K. Liu, J.M. Guralnik, L. Celic, and M.H. Criqui The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study Ann Int Med 136 2002 873 883
36. P. Bernasconi, E. Torchiana, P. Confalonieri, R. Brugnoni, R. Barresi, and M. Mora Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine J Clin Invest 96 1995 1137 1144
37. L. Zhou, and H. Lu Targeting fibrosis in Duchenne muscular dystrophy J Neuropathol Exp Neurol 69 2010 771 776
38. M. Bourraindeloup, C. Adamy, G. Candiani, M. Cailleret, M.C. Bourin, and T. Badoual N-acetylcysteine treatment normalizes serum tumor necrosis factor-alpha level and hinders the progression of cardiac injury in hypertensive rats Circulation 110 2004 2003 2009
39. R. Lombardi, G. Rodriguez, S.N. Chen, C.M. Ripplinger, W. Li, and J. Chen Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms Circulation 119 2009 1398 1407
40. A.J. Marian, V. Senthil, S.N. Chen, and R. Lombardi Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation J Am Coll Cardiol 47 2006 827 834
41. R.M. Liu, and K.A. Gaston Pravia Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis Free Radic Biol Med 48 2010 1 15
42. I. Medved, M.J. Brown, A.R. Bjorksten, K.T. Murphy, A.C. Petersen, and S. Sostaric N-acetylcysteine enhances muscle cysteine and glutathione availability and attenuates fatigue during prolonged exercise in endurance-trained individuals J Appl Physiol 97 2004 1477 1485
43. J.R. Terrill, H.G. Radley-Crabb, M.D. Grounds, and P.G. Arthur N-Acetylcysteine treatment of dystrophic mdx mice results in protein thiol modifications and inhibition of exercise induced myofibre necrosis Neuromuscul Disord 22 2012 427 434
44. M. Nyberg, J.R. Blackwell, R. Damsgaard, A.M. Jones, Y. Hellsten, and S.P. Mortensen Lifelong physical activity prevents an age-related reduction in arterial and skeletal muscle nitric oxide bioavailability in humans J Physiol 590 Pt 21 2012 5361 5370
45. L.L. Ji, R. Fu, and E.W. Mitchell Glutathione and antioxidant enzymes in skeletal muscle: effects of fiber type and exercise intensity J Appl Physiol 73 1992 1854 1859
46. S.K. Powers, and M.J. Jackson Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production Physiol Rev 88 2008 1243 1276
47. R.B. Armstrong, and M.H. Laughlin Metabolic indicators of fibre recruitment in mammalian muscles during locomotion J Exp Biol 115 1985 201 213
48. J.W. Stevens, E. Simpson, S. Harnan, H. Squires, Y. Meng, and S. Thomas Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication Br J Surg 99 2012 1630 1638
49. G. De Mattia, M.C. Bravi, O. Laurenti, M. Cassone-Faldetta, A. Proietti, and O. De Luca Reduction of oxidative stress by oral N-acetyl-L-cysteine treatment decreases plasma soluble vascular cell adhesion molecule-1 concentrations in non-obese, non-dyslipidaemic, normotensive, patients with non-insulin-dependent diabetes Diabetologia 41 1998 1392 1396
50. A. Jeremias, G. Soodini, E. Gelfand, Y. Xu, R.C. Stanton, and E.S. Horton Effects of N-acetyl-cysteine on endothelial function and inflammation in patients with type 2 diabetes mellitus Heart Int 4 2009 e7
51. V. Martina, A. Masha, V.R. Gigliardi, L. Brocato, E. Manzato, and A. Berchio Long-term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes Diabetes Care 31 2008 940 944
52. C. Koechlin, A. Couillard, D. Simar, J.P. Cristol, H. Bellet, and M. Hayot Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 169 2004 1022 1027
53. S. Reagan-Shaw, M. Nihal, and N. Ahmad Dose translation from animal to human studies revisited FASEB J 22 2008 659 661